Daewoong Pharma Strategic Asset Allocation Index
Daewoong Pharma strategic asset allocation index. Daewoong Pharma (069620) has a Strategic Asset Allocation Index of 55.7% as of June 2023. Strategic assets (PP&E of ₩459.49 Billion plus long-term investments of ₩-) total ₩459.49 Billion, measured against net assets of ₩824.97 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible equity quality of Daewoong Pharma to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Daewoong Pharma (2007–2022)
Strategic asset allocation index of Daewoong Pharma from 2007 to 2022. This chart shows how Daewoong Pharma's Strategic Asset Allocation Index has evolved across 14 annual periods from 2007 to 2022. As of June 2023, the index stands at 55.7%, representing strategic assets of ₩459.49 Billion against net assets of ₩824.97 Billion KRW.
Daewoong Pharma Strategic Asset Allocation Index by Year (2007–2022)
Daewoong Pharma strategic asset allocation index by year from 2007 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Daewoong Pharma from 2007 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 069620 stock market capitalisation.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 59.5% | ₩440.89 Billion | ₩440.89 Billion | ₩- | ₩741.22 Billion | ▲ +3.1 pp |
| 2021 | 56.4% | ₩395.87 Billion | ₩395.87 Billion | ₩- | ₩702.41 Billion | ▼ -0.3 pp |
| 2020 | 56.6% | ₩393.69 Billion | ₩393.69 Billion | ₩- | ₩695.25 Billion | ▼ -10.0 pp |
| 2019 | 66.7% | ₩423.85 Billion | ₩391.71 Billion | ₩32.14 Billion | ₩635.92 Billion | ▼ -2.3 pp |
| 2018 | 69.0% | ₩419.25 Billion | ₩401.13 Billion | ₩18.12 Billion | ₩607.81 Billion | ▲ +5.0 pp |
| 2017 | 64.0% | ₩404.20 Billion | ₩396.16 Billion | ₩8.05 Billion | ₩631.54 Billion | ▲ +1.8 pp |
| 2016 | 62.2% | ₩375.75 Billion | ₩367.08 Billion | ₩8.67 Billion | ₩604.55 Billion | ▲ +16.3 pp |
| 2015 | 45.9% | ₩266.11 Billion | ₩255.84 Billion | ₩10.26 Billion | ₩580.24 Billion | ▲ +8.0 pp |
| 2014 | 37.8% | ₩172.36 Billion | ₩160.11 Billion | ₩12.25 Billion | ₩455.51 Billion | ▲ +3.7 pp |
| 2013 | 34.1% | ₩149.36 Billion | ₩132.62 Billion | ₩16.74 Billion | ₩437.96 Billion | ▲ +4.4 pp |
| 2012 | 29.7% | ₩114.86 Billion | ₩114.86 Billion | ₩- | ₩386.59 Billion | ▼ -0.1 pp |
| 2011 | 29.8% | ₩107.97 Billion | ₩107.97 Billion | ₩- | ₩362.42 Billion | ▼ -19.7 pp |
| 2008 | 49.5% | ₩138.06 Billion | ₩138.06 Billion | ₩- | ₩278.85 Billion | ▲ +6.7 pp |
| 2007 | 42.8% | ₩115.42 Billion | ₩115.42 Billion | ₩- | ₩269.57 Billion | — |